Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Matthew Ocko Insider Profile
4 Followers
Matthew Ocko, Director at Zymergen, holds 3.39M shares in Rocket Lab USA (Ticker: RKLB), holds 0.00 shares in Zymergen (Ticker: ZY). Most recently, Matthew Ocko Sold ― shares of Rocket Lab USA on Nov 18, 2024 for an estimated value of 96.74M.
Matthew Ocko Zymergen (ZY)Director
Zymergen (ZY)
Director
Not Ranked
Matthew Ocko has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Matthew Ocko holds in companies
Most Profitable Insider Trade
The most profitable trade made by Matthew Ocko
Matthew Ocko's Trading History
Zymergen
Oct 19, 2022
―
Uninformative Sell
―
$0.00
Rocket Lab USA
Nov 18, 2024
Director
Informative Sell
96.74M
$78.81M
List of latest transactions for each holding click on a transaction to see Matthew Ocko's performance on stock
You May Also Like
Matthew Ocko insider profile FAQ
What is the percentage of profitable transactions made by Matthew Ocko?
The percentage of profitable transactions made by Matthew Ocko is ―.
What is the average return per transaction made by Matthew Ocko?
The average return per transaction made by Matthew Ocko is ―.
What stocks does Matthew Ocko hold?
Matthew Ocko holds: ZY, RKLB stocks.
What was Matthew Ocko’s latest transaction?
Matthew Ocko latest transaction was an Informative Sell of $96.74M.
What was Matthew Ocko's most profitable transaction?
Matthew Ocko’s most profitable transaction was an Informative Sell of RKLB stock on November 18, 2024. The return on the trade was -20.50%.
What is Matthew Ocko's role in Zymergen?
Matthew Ocko's role in Zymergen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.